MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 12-16-2024
Enzo Biochem ROA Ratio 2011-2026 | ENZ
Annual ROA Ratio Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30.41 | 16.65 | -24.15 | 6.93 | -25.34 | 2.33 | -10.15 | -2.33 | 40.5 | -3.34 | -15.49 | -30.93 | -56.81 | -11.84 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 40.5 | -56.81 | -10.31 |
Quarterly ROA Ratio Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.04 | -12.54 | -33.62 | -51.46 | -58.78 | -43.96 | -48.63 | -32.23 | -19.77 | -4.76 | -2.47 | 3.96 | -4.67 | -2.27 | -7.51 | -9.01 | -8.53 | -14.9 | -17.0 | 8.9 | -34.76 | -35.0 | -35.61 | -61.55 | -74.84 | -69.08 | -63.33 | -58.04 | 311.73 | 310.98 | 343.21 | 342.48 | -160.71 | -153.41 | -173.38 | -165.58 | -142.47 | -154.39 | -171.65 | -183.93 | -240.84 | -239.67 | -240.01 | -238.95 | -157.13 | -157.86 | -191.86 | -192.48 | -225.91 | -224.72 | -189.13 | -187.89 | -4.32 | -3.67 | -4.11 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 343.21 | -240.84 | -60.02 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
-189.54 | $ 1.27 | -22.09 % | $ 1.69 M |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 15.81 | -2.35 % | $ 478 M | USA |
 |
Agilent Technologies
A
|
11.3 | $ 111.6 | -1.45 % | $ 33.9 B | USA |
 |
Castle Biosciences
CSTL
|
-4.18 | $ 19.18 | 1.59 % | $ 556 M | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 141.04 | -1.54 % | $ 22.4 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 19.85 | -3.12 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 93.57 | -3.21 % | $ 6.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 417.23 | -0.46 % | $ 12 B | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 037.75 | -0.4 % | $ 21.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Myriad Genetics
MYGN
|
-51.8 | $ 3.62 | -0.14 % | $ 335 M | USA |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.28 | -0.96 % | $ 1.06 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 153.0 | -3.85 % | $ 7.58 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 18.63 | -1.61 % | $ 417 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 188.85 | -4.1 % | $ 18.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
3.33 | $ 25.25 | -0.98 % | $ 23.9 B |  Niderland |
 |
Guardant Health
GH
|
-20.67 | $ 94.7 | -4.02 % | $ 11.9 B | USA |
 |
Senseonics Holdings
SENS
|
-54.72 | $ 5.72 | -1.8 % | $ 239 M | USA |
 |
Personalis
PSNL
|
-24.32 | $ 6.46 | -3.73 % | $ 576 M | USA |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 53.0 | 0.02 % | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 117.71 | 0.53 % | $ 9.71 B |  Irlanda |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-83.65 | $ 2.36 | -2.12 % | $ 5.42 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 252.45 | -0.62 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 438.41 | -2.17 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.56 | -3.63 % | $ 201 M | Irlanda |
 |
Celcuity
CELC
|
-37.95 | $ 135.32 | 0.45 % | $ 6.33 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 48.53 | -8.35 % | $ 2.9 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 8.22 | -2.55 % | $ 1.78 B | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 330.33 | -0.86 % | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 186.95 | -0.53 % | $ 20.8 B | USA |